Issue 85, 2024

A robust collagen-targeting MRI peptide contrast agent for in vivo imaging of hepatic fibrosis

Abstract

We herein report the construction of a robust MRI peptide contrast agent Gd-ICTP with superior selectivity for type I collagen, enabling the accurate and non-invasive detection of hepatic fibrosis in vivo.

Graphical abstract: A robust collagen-targeting MRI peptide contrast agent for in vivo imaging of hepatic fibrosis

Supplementary files

Article information

Article type
Communication
Submitted
12 Feb 2024
Accepted
27 Sep 2024
First published
27 Sep 2024

Chem. Commun., 2024,60, 12453-12456

A robust collagen-targeting MRI peptide contrast agent for in vivo imaging of hepatic fibrosis

Z. Liu, L. Nian, X. Cai, Y. Hu, J. Lei and J. Xiao, Chem. Commun., 2024, 60, 12453 DOI: 10.1039/D4CC00702F

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements